MedWatcher provides access to valuable feedback from cancer patients

MedWatcher, XO Life's innovative health platform, enables patients in Germany to obtain important information about their illnesses and drug therapies. The platform, which was developed in collaboration with scientific institutions, uses patient-reported outcomes (PROs) for the real-world evaluation of therapies. Since August 2023, MedWatcher has been working with the “European Organization for Research and Treatment of Cancer” (EORTC) to combine oncological research with patient feedback. Patients can now complete standardized EORTC quality of life questionnaires directly via the platform, which provides both patients and researchers with important insights. This is part of XO Life's efforts to build a comprehensive patient platform through MedWatcher that delivers real world data and improves patients' quality of life.